SavedAdd your journal

Journals / Haydarpaşa Numune Medical Journal / 2020 / Cilt: 60 - Sayı: 2

The Association of High Red Blood Cell Distribution Width with Metabolic Syndrome in Stable Coronary Artery Disease

Kıvılcım ÖZDEN
Aysun Erdem YAMAN
Pages
123–128
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Future studies are needed to demonstrate the role of RDW on MetS to predict long-term cardiovascular events.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Metabolic syndrome (MetS) increases the risk of cardiovascular diseases.
📊
Key Findings & Data:The value of red blood cell width (RDW ) has been demonstrated in several studies in coronary artery disease.
💡
Conclusion & Impact:Future studies are needed to demonstrate the role of RDW on MetS to predict long-term cardiovascular events.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Introduction: Metabolic syndrome (MetS) increases the risk of cardiovascular diseases. The value of red blood cell width (RDW ) has been demonstrated in several studies in coronary artery disease. This study aims to investigate the significance of RDW in MetS patients with coronary artery disease (CAD).Methods: In this study, 120 of 89 patients undergoing coronary angiography were included. The whole group was divided into two groups according to coronary stenosis as noncritical and critical CAD. The study group was also divided into MetS and non-MetS. The cardiometabolic risk parameters were evaluated and RDW was calculated from complete blood count.Results: MetS prevalence was not significantly different between critic (71%) and noncritical CAD (59.5%) groups. RDW was significantly associated with MetS in the whole study population (p=0.037) and was significantly higher in the critic-CAD-MetS group (p=0.018).Discussion and Conclusion: RDW is an inflammation marker that is associated with MetS patients in CAD. The higher value of RDW is associated with critic-CAD. Future studies are needed to demonstrate the role of RDW on MetS to predict long-term cardiovascular events.

🔖

Cite This Article

ÖZDEN, K., YAMAN, A. E. (2020). The Association of High Red Blood Cell Distribution Width with Metabolic Syndrome in Stable Coronary Artery Disease. Haydarpaşa Numune Medical Journal, Cilt: 60 - Sayı: 2, 123–128. https://ajindex.com/articles/216781

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Ford ES. The metabolic syndrome and mortality from cardio-vascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 2004;173:309–14
  2. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595–607
  3. Reaven GM. The metabolic syndrome: requiescat in pace. Clin Chem 2005;51:931–8
  4. Karnad A, Poskitt TR. The automated complete blood cell count. Use of the red blood cell volume distribution width and mean platelet volume in evaluating anemia and throm-bocytopenia. Arch Intern Med 1985;145:1270–2
  5. Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M; for the Cholesterol and Recurrent Events (CARE) Trial Investiga-tors. Relation Between Red Blood Cell Distribution Width and Cardiovascular Event Rate in People With Coronary Disease. Circulation 2008;117:163–8
  6. Sun XP, Chen WM, Sun ZJ, Ding XS, Gao XY, Liang SW, et al. Impact of red blood cell distribution width on long-term mor-tality in patients with ST-elevation myocardial infarction. Car-diology 2014;128:343–8
  7. Osadnik T, Strzelczyk J, Hawranek M, Lekston A, Wasilewski J, Kurek A, et al. Red cell distribution width is associated with long-term prognosis in patients with stable coronary artery disease. BMC Cardiovasc Disord 2013;13:113
  8. Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med 2009;133:628–32
  9. Zhang PY, Xu X, Li XC. Cardiovascular diseases: oxidative dam-age and antioxidant protection. Eur Rev Med Pharmacol Sci 2014;18:3091–6
  10. Friedman JS, Lopez MF, Fleming MD, Rivera A, Martin FM, Welsh ML, et al. SOD2-deficiency anemia: protein oxida-tion and altered protein expression reveal targets of dam-age, stress response, and antioxidant responsiveness. Blood 2004;104:2565–73
  11. Serné EH, de Jongh RT, Eringa EC, IJzerman RG, Stehouwer CD. Microvascular dysfunction: a potential pathophysiological role in the metabolic syndrome. Hypertension 2007;50:204–11
  12. Elnakish MT, Hassanain HH, Janssen PM, Angelos MG, Khan M. Emerging role of oxidative stress in metabolic syndrome and cardiovascular diseases: important role of Rac/NADPH ox-idase. J Pathol 2013;231:290–300
  13. Yubero-Serrano EM, Delgado-Lista J, Peña-Orihuela P, Perez-Martinez P, Fuentes F, Marin C, et al. Oxidative stress is associ-ated with t